球体储库生物人工肝在猪肝切除术后肝衰竭模型中的随机试验
研究在85%肝切除的野生型大白猪中随机分为标准内科治疗组、无肝细胞生物人工肝对照组和200克猪原代肝细胞球体储库生物人工肝组,比较生存、血清化学和肝再生。200克组6只中5只存活至90小时,氨、颅内压和国际标准化比值显著降低,肝再生增加,但结论认为需进一步临床测试。
要点
- 200克球体储库生物人工肝组6只中5只存活至肝切除后90小时,两个对照组均在51小时前达到死亡等效终点。
- 200克组平均氨、颅内压和国际标准化比值显著低于对照组。
- 200克组肝切除后48小时残余肝再生体积和Ki-67阳性染色较对照组增加。
核心结论
- 球体储库生物人工肝改善了肝切除术后急性肝衰竭猪的生存、降低了氨并加速了肝再生,生存改善与神经保护获益相关,这些有利结果需进一步临床测试。
研究设计与样本
- 野生型大白猪(20 kg-30 kg)行颅内压探头置入后接受85%肝切除,用计算机断层扫描体积测定评估切除范围和肝切除后48小时残余肝再生。
- 动物在肝切除后24-48小时按治疗随机分为三组:第1组标准内科治疗(n=6);第2组标准内科治疗加无肝细胞的生物人工肝治疗(0 g,n=6);第3组标准内科治疗加200克猪原代肝细胞球体的球体储库生物人工肝治疗(200 g,n=6)。
主要发现
- 主要终点为肝切除后存活至90小时,死亡等效定义为不可反应的4级肝性脑病或颅内压大于20 mmHg伴临床脑疝证据。
- 两个对照组(标准内科治疗组和0 g组)所有动物均在肝切除后51小时前达到死亡等效。
- 200 g组6只中5只存活至90小时(P < 0.01)。
- 200 g组平均氨、颅内压和国际标准化比值显著低于对照组。
- 计算机断层扫描体积测定显示200 g组肝切除后48小时体积再生较标准内科治疗组(P < 0.01)和0 g组(P < 0.01)增加;Ki-67染色显示肝切除后48小时阳性染色增加(P < 0.01)。
局限性
- 作者结论指出这些有利结果需进一步临床测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute liver failure (ALF) is a catastrophic condition that can occur after major liver resection. The aim of this study was to determine the effects of the spheroid reservoir bio-artificial liver (SRBAL) on survival, serum chemistry, and liver regeneration in posthepatectomy ALF pigs. Wild-type large white swine (20 kg-30 kg) underwent intracranial pressure (ICP) probe placement followed by 85% hepatectomy. Computed tomography (CT) volumetrics were performed to measure the extent of resection, and at 48 hours following hepatectomy to assess regeneration of the remnant liver. Animals were randomized into three groups based on treatment delivered 24-48 hours after hepatectomy: Group1-standard medical therapy (SMT, n = 6); Group2-SMT plus bio-artificial liver treatment using no hepatocytes (0 g, n = 6); and Group3-SMT plus SRBAL treatment using 200 g of primary porcine hepatocyte spheroids (200 g, n = 6). The primary endpoint was survival to 90 hours following hepatectomy. Death equivalent was defined as unresponsive grade 4 hepatic encephalopathy or ICP greater than 20 mmHg with clinical evidence of brain herniation. All animals in both (SMT and 0 g) control groups met the death equivalent before 51 hours following hepatectomy. Five of 6 animals in the 200-g group survived to 90 hours (P < 0.01). The mean ammonia, ICP, and international normalized ratio values were significantly lower in the 200-g group. CT volumetrics demonstrated increased volume regeneration at 48 hours following hepatectomy in the 200-g group compared with the SMT (P < 0.01) and 0-g (P < 0.01) groups. Ki-67 staining showed increased positive staining at 48 hours following hepatectomy (P < 0.01). Conclusion: The SRBAL improved survival, reduced ammonia, and accelerated liver regeneration in posthepatectomy ALF. Improved survival was associated with a neuroprotective benefit of SRBAL therapy. These favorable results warrant further clinical testing of the SRBAL.
引用
- Chen HS, Joo DJ, Shaheen M, et al. Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure. Hepatology. 2018. PMID: 30022502. doi:10.1002/hep.30184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。